Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,800
Closed -$438K 4259
2026
Q1
$438K Hold
5,800
﹤0.01% 3174
2025
Q4
$432K Buy
+5,800
New +$424K ﹤0.01% 3313
2024
Q1
Sell
-3,500
Closed -$250K 2366
2023
Q4
$250K Buy
+3,500
New +$244K ﹤0.01% 1746
2023
Q1
Sell
-3,500
Closed -$262K 2371
2022
Q4
$262K Sell
3,500
-1,000
-22% -$71.2K ﹤0.01% 1230
2022
Q3
$290K Hold
4,500
﹤0.01% 1233
2022
Q2
$312K Buy
+4,500
New +$334K ﹤0.01% 1238

Other funds holding HOLX

Steven Cohen's HOLX Position: Q2 2026 in Review

Steven Cohen sold out of Hologic (HOLX) in Q2 2026, closing a stake of 71,776 shares — an estimated $5.43M sold.

Steven Cohen first reported a position in HOLX in Q3 2015 and held it in 28 quarters. The position peaked at $132M in Q3 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Steven Cohen reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 71,776 Hologic shares in Q2 2026, an estimated $5.43M.
  • Steven Cohen first reported a position in Hologic in Q3 2015 and held it in 28 quarters.
  • Steven Cohen's Hologic position peaked at $132M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.